
═══════════════════════════════════════════════════════════════════════════════
Figure X. Pathway Activity Across Disease Stages in Chronic HBV Infection
═══════════════════════════════════════════════════════════════════════════════

Heatmap showing Z-score normalized pathway activity across five disease stages
of chronic HBV infection. Analysis performed on 243,000 single cells from 
GSE182159 dataset.

COLOR SCALE:
- Red: Elevated pathway activity (Z-score > 0)
- Blue: Reduced pathway activity (Z-score < 0)
- White: Average activity (Z-score ≈ 0)

DISEASE STAGES (columns):
- NL: Normal Liver (healthy controls, n=42,579 cells)
- IT: Immune Tolerant phase (n=49,179 cells)
- IA: Immune Active phase (n=62,545 cells)
- AR: Acute Resolved (n=45,452 cells)
- AC: Acute Chronic (n=43,245 cells)

PATHWAYS (rows):

1. mTOR_signaling
   Genes: MTOR, RPTOR, RICTOR, AKT1, PIK3CA, TSC1, TSC2, RHEB, EIF4EBP1, 
          RPS6KB1, ULK1, PTEN
   Pattern: Low in NL (-1.60), elevated in IT (+0.79) and disease stages
   Significance: Central node in HBsAg-IL15Rβ-mTOR axis

2. glycolysis
   Genes: HK1, HK2, GPI, PFKM, ALDOA, GAPDH, PGK1, ENO1, PKM, LDHA, LDHB,
          SLC2A1, SLC2A3
   Pattern: Highest in NL (+1.05), progressively decreased in AC (-1.53)
   Significance: Metabolic dysfunction in chronic infection

3. oxidative_phosphorylation
   Genes: MT-ND1-5, MT-CYB, MT-CO1-3, MT-ATP6, MT-ATP8
   Pattern: Lowest in NL (-1.65), highest in IT (+0.97)
   Significance: Mitochondrial stress signature; defines IT-exclusive 
                 clusters 21 and 23

4. nk_cell_cytotoxicity
   Genes: PRF1, GZMA, GZMB, GZMK, GNLY, FASLG, IFNG, TNF, KLRK1, KLRD1,
          NCR1, NCR3, CD226
   Pattern: Highest in NL (+1.48), dramatically reduced in AC (-1.27)
   Significance: NK cell functional collapse; hallmark of immune tolerance

5. il15_signaling
   Genes: IL15, IL15RA, IL2RB, IL2RG, JAK1, JAK3, STAT5A, STAT5B, SYK, LCK
   Pattern: Low in NL (-0.40), elevated in IA (+0.66) and AR (+0.83)
   Significance: Altered IL-15 axis; HBsAg binds IL-15Rβ (Yu et al. 2025)

6. b_cell_differentiation
   Genes: PAX5, BCL6, PRDM1, IRF4, XBP1, CD79A, CD79B, MS4A1, CD19, CD22,
          JCHAIN, MZB1
   Pattern: Highest in AC (+1.64), lowest in AR (-1.05)
   Significance: B cell maturation arrest; IT-exclusive naive B cells

─────────────────────────────────────────────────────────────────────────────────
KEY OBSERVATIONS:
─────────────────────────────────────────────────────────────────────────────────

1. IT Phase Signature (column 2):
   - OXPHOS markedly elevated (+0.97): Mitochondrial stress
   - mTOR elevated (+0.79): Compensatory metabolic response
   - NK cytotoxicity near baseline (+0.07): Functional impairment vs NL

2. NL vs Disease Contrast:
   - NL shows highest NK cytotoxicity (+1.48) and glycolysis (+1.05)
   - Disease stages show progressive NK collapse and metabolic shift

3. Disease Progression Pattern:
   - AC shows most severe NK collapse (-1.27) and glycolysis deficit (-1.53)
   - Suggests cumulative immune dysfunction with disease chronicity

─────────────────────────────────────────────────────────────────────────────────
CONCLUSION:
─────────────────────────────────────────────────────────────────────────────────
The pathway activity heatmap reveals distinct metabolic and immunological 
signatures across HBV infection stages. The IT phase is characterized by 
elevated OXPHOS (mitochondrial stress), maintained mTOR activity, and 
reduced NK cell cytotoxicity compared to healthy controls. These findings 
support the HBsAg-IL15Rβ-mTOR axis model of immune tolerance, wherein 
HBsAg-mediated signaling disruption leads to NK cell metabolic dysfunction 
and functional exhaustion.

Reference: Yu Y, et al. Cell Death Dis. 2025
═══════════════════════════════════════════════════════════════════════════════
